Cargando…
Novel solid-phase strategy for the synthesis of ligand-targeted fluorescent-labelled chelating peptide conjugates as a theranostic tool for cancer
In this article, we have successfully designed and demonstrated a novel continuous process for assembling targeting ligands, peptidic spacers, fluorescent tags and a chelating core for the attachment of cytotoxic molecules, radiotracers, nanomaterials in a standard Fmoc solid-phase peptide synthesis...
Autores principales: | Sengupta, Sagnik, Krishnan, Mena Asha, Dudhe, Premansh, Reddy, Ramesh B, Giri, Bishnubasu, Chattopadhyay, Sudeshna, Chelvam, Venkatesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204756/ https://www.ncbi.nlm.nih.gov/pubmed/30410628 http://dx.doi.org/10.3762/bjoc.14.244 |
Ejemplares similares
-
Synthesis of 1-indolyl-3,5,8-substituted γ-carbolines: one-pot solvent-free protocol and biological evaluation
por: Dudhe, Premansh, et al.
Publicado: (2021) -
Chelating Rotaxane Ligands as Fluorescent Sensors for Metal Ions
por: Denis, Mathieu, et al.
Publicado: (2018) -
Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for (203)Pb and (212)Pb-Based Theranostics
por: Li, Mengshi, et al.
Publicado: (2023) -
AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications
por: Fersing, Cyril, et al.
Publicado: (2022) -
DNA-supramolecule conjugates in theranostics
por: Chen, Kun, et al.
Publicado: (2019)